D-0442-2024 Class I Terminated
FDA drug recall D-0442-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Mar 21, 2024 and is designated Class I. Reason for recall: Superpotent Drug: Due to overfilling of drug powder The recall status is terminated (terminated Jul 21, 2025). Affected quantity: 821 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 24, 2024
- Initiation Date
- Mar 21, 2024
- Termination Date
- Jul 21, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 821 bottles
Product description
Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 150 mL bottle, NDC 69238-2261-7; (c)300 mL bottle, NDC 69238-2261-5; Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807
Reason for recall
Superpotent Drug: Due to overfilling of drug powder
Distribution pattern
Nationwide in the USA.
Code information
Lot # (a) 22613003A, Exp. date 09/30/2025; (b) 22613004A, 22613005A, Exp. date 09/30/2025; (c) 22613005B, Exp. date 09/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0442-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026